United States Pharmaceuticals

CorMedix Inc (CRMD)

Track

Track

CorMedix Inc. experienced multiple divestments by corporate insiders between November 2025 and January 2026. Directors and executives, including Janet Dillione and Joseph Todisco, executed various sell orders. The most recent activity occurred on January 21, 2026. No buying interest was reported during this period, reflecting a consistent pattern of equity reduction by leadership.
Ticker: CRMD Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for CorMedix Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Dillione Janet Non-Executive Director
Transaction date
Sale
Price
400.92
Quantity 11,755 +17.1%
Value US$4,862,141
3.1
Janet Dillione Director Non-Executive Director
Transaction date
Proposed sale
Price
25.33
Quantity 17,561
Value US$3,286,687
4.1
DUNTON ALAN W Non-Executive Director
Transaction date
Sale
Price
46.68
Quantity 18,995 +9.5%
Value US$1,219,572
4.1
Alan Dunton Director Non-Executive Director
Transaction date
Proposed sale
Price
12.97
Quantity 20,000
Value US$259,400
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Sale
Price
12.00
Quantity 30,000 -5.6%
Value US$360,000
3.9
Joseph Todisco Officer Officer
Transaction date
Proposed sale
Price
11.97
Quantity 30,000
Value US$359,149
3.1
Dillione Janet Non-Executive Director
Transaction date
Sale
Price
12.00
Quantity 34,000 -41.2%
Value US$408,000
3.5
Lefkowitz Steven W Non-Executive Director
Transaction date
Sale
Price
11.88
Quantity 40,000 -33.2%
Value US$475,200
3.5
Lefkowitz Steven W Director Non-Executive Director
Transaction date
Proposed sale
Price
11.26
Quantity 40,000
Value US$450,400
3.1
Janet Dillione BOD
Transaction date
Proposed sale
Price
12.00
Quantity 34,000
Value US$408,000
3.1
Dillione Janet Non-Executive Director
Transaction date
Sale
Price
10.00
Quantity 46,657 -49.0%
Value US$466,570
3.1
Dillione Janet Non-Executive Director
Transaction date
Sale
Price
9.93
Quantity 26,343 -35.2%
Value US$261,586
3.1
Janet Dillione Director Non-Executive Director
Transaction date
Proposed sale
Price
9.97
Quantity 73,000
Value US$727,927
3.1
Dillione Janet Non-Executive Director
Transaction date
Sale
Price
11.42
Quantity 30,000 -38.2%
Value US$342,600
3.1
Dillione Janet Director Non-Executive Director
Transaction date
Proposed sale
Price
10.94
Quantity 30,000
Value US$328,200
2.3
Erin Mistry Former Officer Officer
Transaction date
Proposed sale
Price
10.98
Quantity 13,543
Value US$148,719
2.3
Erin Mistry Former Officer Officer
Transaction date
Proposed sale
Price
10.97
Quantity 13,908
Value US$152,503
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
11.02
Quantity 25,000 +14.2%
Value US$275,500
4.1
DUNTON ALAN W Non-Executive Director
Transaction date
Sale
Price
13.13
Quantity 10,000 -19.9%
Value US$131,300
4.1
DUNTON ALAN W Director Non-Executive Director
Transaction date
Proposed sale
Price
13.10
Quantity 10,000
Value US$130,950
3.9
Todisco Joseph Officer Officer
Transaction date
Proposed sale
Price
12.97
Quantity 50,000
Value US$648,569
3.9
Todisco Joseph Chief Executive Officer Officer
Transaction date
Sale
Price
13.00
Quantity 50,000 -8.9%
Value US$650,000
3.5
Hurlburt Elizabeth Chief Operating Officer Officer
Transaction date
Sale
Price
13.08
Quantity 41,121 -18.9%
Value US$537,863
3.5
Hurlburt Elizabeth Chief Operating Officer Officer
Transaction date
Sale
Price
13.51
Quantity 12,876 -6.8%
Value US$173,955
3.2
Zelnick Kaufman Beth Chief Legal Officer Officer
Transaction date
Sale
Price
12.82
Quantity 400 -0.2%
Value US$5,128
3.2
Zelnick Kaufman Beth Chief Legal Officer Officer
Transaction date
Sale
Price
13.41
Quantity 49,600 -21.5%
Value US$665,136
3.2
Zelnick Kaufman Beth Officer Officer
Transaction date
Proposed sale
Price
13.46
Quantity 50,000
Value US$673,000
3.5
Hurlburt Elizabeth Officer Officer
Transaction date
Proposed sale
Price
13.50
Quantity 53,997
Value US$728,959
3.3
David Matthew T Former Officer Officer
Transaction date
Proposed sale
Price
14.50
Quantity 300,000
Value US$4,350,000
3.5
Hurlburt Elizabeth EVP Officer
Transaction date
Sale
Price
11.18
Quantity 140,027 -75.5%
Value US$1,565,670
3.5
Hurlburt Elizabeth Officer Officer
Transaction date
Proposed sale
Price
11.12
Quantity 140,027
Value US$1,556,416
2.3
Mistry Erin EVP, Chief Commercial Officer Officer
Transaction date
Purchase
Price
9.99
Quantity 1,500 +3.0%
Value US$14,985
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.74
Quantity 13,561 +4.0%
Value US$50,718
4.1
DUNTON ALAN W Non-Executive Director
Transaction date
Purchase
Price
3.30
Quantity 3,000 +24.5%
Value US$9,900
4.1
DUNTON ALAN W Non-Executive Director
Transaction date
Purchase
Price
3.45
Quantity 3,000 +32.4%
Value US$10,350
2.3
Mistry Erin Chief Commercial Officer Officer
Transaction date
Purchase
Price
4.00
Quantity 1,000 +25.6%
Value US$4,000
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.71
Quantity 10,000 +4.8%
Value US$37,100
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
4.54
Quantity 6,000 +3.7%
Value US$27,258
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.82
Quantity 20,000 +9.0%
Value US$76,400
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.92
Quantity 4,700 +2.2%
Value US$18,424
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
3.78
Quantity 5,000 +3.2%
Value US$18,900
3.9
Todisco Joseph Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.38
Quantity 10,000 +4.8%
Value US$33,800
3.3
David Matthew T Interim CEO and CFO Officer
Transaction date
Purchase
Price
4.50
Quantity 1,000 +46.5%
Value US$4,500
3.3
David Matthew T Interim CEO and CFO Officer
Transaction date
Purchase
Price
4.50
Quantity 1,000 +46.5%
Value US$4,500
3.3
David Matthew T Interim CEO and CFO Officer
Transaction date
Purchase
Price
5.07
Quantity 1,000 +87.0%
Value US$5,070
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
5.14
Quantity 10,000 +6.1%
Value US$51,400
3.5
Masson-Hurlburt Elizabeth EVP, Head of Clinical Ops Officer
Transaction date
Sale
Price
6.92
Quantity 8,000 -100.0%
Value US$55,394
3.5
Lefkowitz Steven W Non-Executive Director
Transaction date
Purchase
Price
3.98
Quantity 2,215 +3.8%
Value US$8,816
3.5
Lefkowitz Steven W Non-Executive Director
Transaction date
Purchase
Price
4.00
Quantity 3,500 +6.4%
Value US$14,000
3.3
David Matthew T Chief Financial Officer Officer
Transaction date
Purchase
Price
4.07
Quantity 1,150 +inf%
Value US$4,680
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
4.27
Quantity 15,300 +11.4%
Value US$65,359
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
4.90
Quantity 8,433 +5.0%
Value US$41,296
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
4.91
Quantity 9,404 +5.8%
Value US$46,176
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
4.86
Quantity 21,082 +15.1%
Value US$102,366
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
4.62
Quantity 4,500 +3.3%
Value US$20,790
2.7
Khan Mehmood Non-Executive Director
Transaction date
Purchase
Price
4.60
Quantity 2,331 +1.8%
Value US$10,723
3.6
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Officer
Transaction date
Purchase
Price
4.35
Quantity 10,000 +11.5%
Value US$43,460
3.6
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Officer
Transaction date
Purchase
Price
4.14
Quantity 7,500 +9.4%
Value US$31,050
3.6
ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Officer
Transaction date
Purchase
Price
4.16
Quantity 10,000 +14.4%
Value US$41,600
2.2
Baluch Khoso Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.14
Quantity 4,830 +8.6%
Value US$19,985
3.5
Mounts Phoebe General Counsel Officer
Transaction date
Purchase
Price
4.03
Quantity 2,525 +54.0%
Value US$10,176
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
4.08
Quantity 15,000 +12.5%
Value US$61,160
4.1
DUNTON ALAN W Non-Executive Director
Transaction date
Purchase
Price
3.95
Quantity 5,000 +400.0%
Value US$19,750
3.1
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
3.85
Quantity 10,000 +9.1%
Value US$38,500
3.5
Mounts Phoebe General Counsel
Transaction date
Purchase
Price
3.05
Quantity 3,250 +228.1%
Value US$9,912
2.2
Baluch Khoso Chief Executive Officer
Transaction date
Purchase
Price
2.61
Quantity 3,500 +6.7%
Value US$9,135
3.5
Mounts Phoebe General Counsel
Transaction date
Purchase
Price
7.04
Quantity 1,425 +inf%
Value US$10,038
Khan Mehmood
Transaction date
Purchase
Price
6.58
Quantity 17,000 +14.7%
Value US$111,925
1.4
Cook Robert W. Chief Financial Officer
Transaction date
Purchase
Price
6.88
Quantity 1,000 +3.8%
Value US$6,879
3.1
Kaplan Myron
Transaction date
Purchase
Price
6.81
Quantity 5,000 +4.8%
Value US$34,050
3.5
Lefkowitz Steven W
Transaction date
Purchase
Price
6.75
Quantity 5,000 +9.9%
Value US$33,750
Cook Robert W. Chief Financial Officer
Transaction date
Purchase
Price
8.18
Quantity 1,000 +3.9%
Value US$8,180
Cook Robert W. Chief Financial Officer
Transaction date
Purchase
Price
8.18
Quantity 1,000 +3.9%
Value US$8,180
Dillione Janet Non-Executive Director
Transaction date
Purchase
Price
8.19
Quantity 6,147 +13.0%
Value US$50,344
Kaplan Myron Non-Executive Director
Transaction date
Purchase
Price
8.06
Quantity 6,000 +6.1%
Value US$48,360
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-22 2026-01-21 S Sale
3.1
Dillione Janet
Non-Executive Director
11,755 +17.1%
400.92
US$4,862,141 		11,755 +17.1% 400.92 US$4,862,141
2026-01-21 2026-01-21 PrS Proposed sale
3.1
Janet Dillione

Director

Non-Executive Director
17,561
25.33
US$3,286,687 		17,561 25.33 US$3,286,687
2026-01-02 2025-12-30 S Sale
4.1
DUNTON ALAN W
Non-Executive Director
18,995 +9.5%
46.68
US$1,219,572 		18,995 +9.5% 46.68 US$1,219,572
2025-12-30 2025-12-30 PrS Proposed sale
4.1
Alan Dunton

Director

Non-Executive Director
20,000
12.97
US$259,400 		20,000 12.97 US$259,400
2025-12-19 2025-12-18 S Sale
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
30,000 -5.6%
12.00
US$360,000 		30,000 -5.6% 12.00 US$360,000
2025-12-18 2025-12-18 PrS Proposed sale
3.9
Joseph Todisco

Officer

Officer
30,000
11.97
US$359,149 		30,000 11.97 US$359,149
2025-12-11 2025-12-09 S Sale
3.1
Dillione Janet
Non-Executive Director
34,000 -41.2%
12.00
US$408,000 		34,000 -41.2% 12.00 US$408,000
2025-12-10 2025-12-09 S Sale
3.5
Lefkowitz Steven W
Non-Executive Director
40,000 -33.2%
11.88
US$475,200 		40,000 -33.2% 11.88 US$475,200
2025-12-09 2025-12-09 PrS Proposed sale
3.5
Lefkowitz Steven W

Director

Non-Executive Director
40,000
11.26
US$450,400 		40,000 11.26 US$450,400
2025-12-09 2025-12-09 PrS Proposed sale
3.1
Janet Dillione

BOD
34,000
12.00
US$408,000 		34,000 12.00 US$408,000
2025-12-04 2025-12-02 S Sale
3.1
Dillione Janet
Non-Executive Director
46,657 -49.0%
10.00
US$466,570 		46,657 -49.0% 10.00 US$466,570
2025-11-26 2025-11-24 S Sale
3.1
Dillione Janet
Non-Executive Director
26,343 -35.2%
9.93
US$261,586 		26,343 -35.2% 9.93 US$261,586
2025-11-24 2025-11-24 PrS Proposed sale
3.1
Janet Dillione

Director

Non-Executive Director
73,000
9.97
US$727,927 		73,000 9.97 US$727,927
2025-11-18 2025-11-14 S Sale
3.1
Dillione Janet
Non-Executive Director
30,000 -38.2%
11.42
US$342,600 		30,000 -38.2% 11.42 US$342,600
2025-11-14 2025-11-14 PrS Proposed sale
3.1
Dillione Janet

Director

Non-Executive Director
30,000
10.94
US$328,200 		30,000 10.94 US$328,200
2025-11-10 2025-11-10 PrS Proposed sale
2.3
Erin Mistry

Former Officer

Officer
13,543
10.98
US$148,719 		13,543 10.98 US$148,719
2025-11-06 2025-11-06 PrS Proposed sale
2.3
Erin Mistry

Former Officer

Officer
13,908
10.97
US$152,503 		13,908 10.97 US$152,503
2025-10-27 2025-10-23 B Purchase
3.1
Kaplan Myron
Non-Executive Director
25,000 +14.2%
11.02
US$275,500 		25,000 +14.2% 11.02 US$275,500
2025-09-16 2025-09-12 S Sale
4.1
DUNTON ALAN W
Non-Executive Director
10,000 -19.9%
13.13
US$131,300 		10,000 -19.9% 13.13 US$131,300
2025-09-12 2025-09-12 PrS Proposed sale
4.1
DUNTON ALAN W

Director

Non-Executive Director
10,000
13.10
US$130,950 		10,000 13.10 US$130,950
2025-09-12 2025-09-12 PrS Proposed sale
3.9
Todisco Joseph

Officer

Officer
50,000
12.97
US$648,569 		50,000 12.97 US$648,569
2025-09-12 2025-09-12 S Sale
3.9
Todisco Joseph

Chief Executive Officer

Officer
50,000 -8.9%
13.00
US$650,000 		50,000 -8.9% 13.00 US$650,000
2025-09-11 2025-09-11 S Sale
3.5
Hurlburt Elizabeth

Chief Operating Officer

Officer
41,121 -18.9%
13.08
US$537,863 		41,121 -18.9% 13.08 US$537,863
2025-09-11 2025-09-09 S Sale
3.5
Hurlburt Elizabeth

Chief Operating Officer

Officer
12,876 -6.8%
13.51
US$173,955 		12,876 -6.8% 13.51 US$173,955
2025-09-11 2025-09-09 S Sale
3.2
Zelnick Kaufman Beth

Chief Legal Officer

Officer
400 -0.2%
12.82
US$5,128 		400 -0.2% 12.82 US$5,128
2025-09-11 2025-09-09 S Sale
3.2
Zelnick Kaufman Beth

Chief Legal Officer

Officer
49,600 -21.5%
13.41
US$665,136 		49,600 -21.5% 13.41 US$665,136
2025-09-09 2025-09-09 PrS Proposed sale
3.2
Zelnick Kaufman Beth

Officer

Officer
50,000
13.46
US$673,000 		50,000 13.46 US$673,000
2025-09-09 2025-09-09 PrS Proposed sale
3.5
Hurlburt Elizabeth

Officer

Officer
53,997
13.50
US$728,959 		53,997 13.50 US$728,959
2025-09-03 2025-09-03 PrS Proposed sale
3.3
David Matthew T

Former Officer

Officer
300,000
14.50
US$4,350,000 		300,000 14.50 US$4,350,000
2024-11-18 2024-11-14 S Sale
3.5
Hurlburt Elizabeth

EVP

Officer
140,027 -75.5%
11.18
US$1,565,670 		140,027 -75.5% 11.18 US$1,565,670
2024-11-14 2024-11-14 PrS Proposed sale
3.5
Hurlburt Elizabeth

Officer

Officer
140,027
11.12
US$1,556,416 		140,027 11.12 US$1,556,416
2024-12-13 2024-10-31 B Purchase
2.3
Mistry Erin

EVP, Chief Commercial Officer

Officer
1,500 +3.0%
9.99
US$14,985 		1,500 +3.0% 9.99 US$14,985
2024-03-14 2024-03-13 B Purchase
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
13,561 +4.0%
3.74
US$50,718 		13,561 +4.0% 3.74 US$50,718
2023-12-18 2023-12-15 B Purchase
4.1
DUNTON ALAN W
Non-Executive Director
3,000 +24.5%
3.30
US$9,900 		3,000 +24.5% 3.30 US$9,900
2023-12-18 2023-12-14 B Purchase
4.1
DUNTON ALAN W
Non-Executive Director
3,000 +32.4%
3.45
US$10,350 		3,000 +32.4% 3.45 US$10,350
2023-11-21 2023-11-17 B Purchase
2.3
Mistry Erin

Chief Commercial Officer

Officer
1,000 +25.6%
4.00
US$4,000 		1,000 +25.6% 4.00 US$4,000
2023-09-08 2023-09-08 B Purchase
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
10,000 +4.8%
3.71
US$37,100 		10,000 +4.8% 3.71 US$37,100
2023-05-19 2023-05-18 B Purchase
3.1
Kaplan Myron
Non-Executive Director
6,000 +3.7%
4.54
US$27,258 		6,000 +3.7% 4.54 US$27,258
2022-11-16 2022-11-15 B Purchase
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
20,000 +9.0%
3.82
US$76,400 		20,000 +9.0% 3.82 US$76,400
2022-08-25 2022-08-24 B Purchase
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
4,700 +2.2%
3.92
US$18,424 		4,700 +2.2% 3.92 US$18,424
2022-05-18 2022-05-17 B Purchase
3.1
Kaplan Myron
Non-Executive Director
5,000 +3.2%
3.78
US$18,900 		5,000 +3.2% 3.78 US$18,900
2022-05-17 2022-05-16 B Purchase
3.9
Todisco Joseph

Chief Executive Officer

Executive Director
10,000 +4.8%
3.38
US$33,800 		10,000 +4.8% 3.38 US$33,800
2021-12-07 2021-12-06 B Purchase
3.3
David Matthew T

Interim CEO and CFO

Officer
1,000 +46.5%
4.50
US$4,500 		1,000 +46.5% 4.50 US$4,500
2021-12-07 2021-12-06 B Purchase
3.3
David Matthew T

Interim CEO and CFO

Officer
1,000 +46.5%
4.50
US$4,500 		1,000 +46.5% 4.50 US$4,500
2021-11-19 2021-11-17 B Purchase
3.3
David Matthew T

Interim CEO and CFO

Officer
1,000 +87.0%
5.07
US$5,070 		1,000 +87.0% 5.07 US$5,070
2021-11-19 2021-11-16 B Purchase
3.1
Kaplan Myron
Non-Executive Director
10,000 +6.1%
5.14
US$51,400 		10,000 +6.1% 5.14 US$51,400
2021-05-25 2021-05-21 S Sale
3.5
Masson-Hurlburt Elizabeth

EVP, Head of Clinical Ops

Officer
8,000 -100.0%
6.92
US$55,394 		8,000 -100.0% 6.92 US$55,394
2020-09-09 2020-09-04 B Purchase
3.5
Lefkowitz Steven W
Non-Executive Director
2,215 +3.8%
3.98
US$8,816 		2,215 +3.8% 3.98 US$8,816
2020-09-09 2020-09-04 B Purchase
3.5
Lefkowitz Steven W
Non-Executive Director
3,500 +6.4%
4.00
US$14,000 		3,500 +6.4% 4.00 US$14,000
2020-09-08 2020-09-03 B Purchase
3.3
David Matthew T

Chief Financial Officer

Officer
1,150 +inf%
4.07
US$4,680 		1,150 +inf% 4.07 US$4,680
2020-09-04 2020-09-02 B Purchase
3.1
Kaplan Myron
Non-Executive Director
15,300 +11.4%
4.27
US$65,359 		15,300 +11.4% 4.27 US$65,359
2020-08-20 2020-08-19 B Purchase
2.7
Khan Mehmood
Non-Executive Director
8,433 +5.0%
4.90
US$41,296 		8,433 +5.0% 4.90 US$41,296
2020-08-20 2020-08-19 B Purchase
2.7
Khan Mehmood
Non-Executive Director
9,404 +5.8%
4.91
US$46,176 		9,404 +5.8% 4.91 US$46,176
2020-08-20 2020-08-18 B Purchase
2.7
Khan Mehmood
Non-Executive Director
21,082 +15.1%
4.86
US$102,366 		21,082 +15.1% 4.86 US$102,366
2020-08-20 2020-08-18 B Purchase
2.7
Khan Mehmood
Non-Executive Director
4,500 +3.3%
4.62
US$20,790 		4,500 +3.3% 4.62 US$20,790
2020-08-20 2020-08-18 B Purchase
2.7
Khan Mehmood
Non-Executive Director
2,331 +1.8%
4.60
US$10,723 		2,331 +1.8% 4.60 US$10,723
2020-08-17 2020-08-14 B Purchase
3.6
ARMSTRONG JR. JOHN L.

Exec VP of Tech Operations

Officer
10,000 +11.5%
4.35
US$43,460 		10,000 +11.5% 4.35 US$43,460
2020-08-17 2020-08-14 B Purchase
3.6
ARMSTRONG JR. JOHN L.

Exec VP of Tech Operations

Officer
7,500 +9.4%
4.14
US$31,050 		7,500 +9.4% 4.14 US$31,050
2020-08-17 2020-08-14 B Purchase
3.6
ARMSTRONG JR. JOHN L.

Exec VP of Tech Operations

Officer
10,000 +14.4%
4.16
US$41,600 		10,000 +14.4% 4.16 US$41,600
2020-08-17 2020-08-13 B Purchase
2.2
Baluch Khoso

Chief Executive Officer

Executive Director
4,830 +8.6%
4.14
US$19,985 		4,830 +8.6% 4.14 US$19,985
2020-08-17 2020-08-13 B Purchase
3.5
Mounts Phoebe

General Counsel

Officer
2,525 +54.0%
4.03
US$10,176 		2,525 +54.0% 4.03 US$10,176
2020-08-17 2020-08-13 B Purchase
3.1
Kaplan Myron
Non-Executive Director
15,000 +12.5%
4.08
US$61,160 		15,000 +12.5% 4.08 US$61,160
2020-08-14 2020-08-12 B Purchase
4.1
DUNTON ALAN W
Non-Executive Director
5,000 +400.0%
3.95
US$19,750 		5,000 +400.0% 3.95 US$19,750
2020-05-18 2020-05-15 B Purchase
3.1
Kaplan Myron
Non-Executive Director
10,000 +9.1%
3.85
US$38,500 		10,000 +9.1% 3.85 US$38,500
2020-03-19 2020-03-18 B Purchase
3.5
Mounts Phoebe

General Counsel
3,250 +228.1%
3.05
US$9,912 		3,250 +228.1% 3.05 US$9,912
2020-03-18 2020-03-18 B Purchase
2.2
Baluch Khoso

Chief Executive Officer
3,500 +6.7%
2.61
US$9,135 		3,500 +6.7% 2.61 US$9,135
2020-01-02 2019-12-30 B Purchase
3.5
Mounts Phoebe

General Counsel
1,425 +inf%
7.04
US$10,038 		1,425 +inf% 7.04 US$10,038
2019-12-17 2019-12-13 B Purchase Khan Mehmood
17,000 +14.7%
6.58
US$111,925 		17,000 +14.7% 6.58 US$111,925
2019-10-01 2019-09-30 B Purchase
1.4
Cook Robert W.

Chief Financial Officer
1,000 +3.8%
6.88
US$6,879 		1,000 +3.8% 6.88 US$6,879
2019-10-01 2019-09-30 B Purchase
3.1
Kaplan Myron
5,000 +4.8%
6.81
US$34,050 		5,000 +4.8% 6.81 US$34,050
2019-10-01 2019-09-27 B Purchase
3.5
Lefkowitz Steven W
5,000 +9.9%
6.75
US$33,750 		5,000 +9.9% 6.75 US$33,750
2019-08-19 2019-08-16 B Purchase Cook Robert W.

Chief Financial Officer
1,000 +3.9%
8.18
US$8,180 		1,000 +3.9% 8.18 US$8,180
2019-08-19 2019-08-16 B Purchase Cook Robert W.

Chief Financial Officer
1,000 +3.9%
8.18
US$8,180 		1,000 +3.9% 8.18 US$8,180
2019-08-16 2019-08-16 B Purchase Dillione Janet Non-Executive Director
6,147 +13.0%
8.19
US$50,344 		6,147 +13.0% 8.19 US$50,344
2019-08-16 2019-08-16 B Purchase Kaplan Myron Non-Executive Director
6,000 +6.1%
8.06
US$48,360 		6,000 +6.1% 8.06 US$48,360
Explore more

More insider trading research around CorMedix Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America